Assay News and Research

RSS

dsDNA Quantification for NGS Quality Control

Andrew Jones discusses the importance of quality control in NGS and the effect that a poorly followed protocol can have on experimental results.

From DeNovix Inc. 1 Sep 2022

Improving 1 µL UV-Vis Spectrophotometry Sample Results

Prior to microvolume spectrophotometry, UV-Vis quantification of biomolecules was performed using quartz cuvettes with a 10mm pathlength.

From DeNovix Inc. 1 Sep 2022

Immunosuppressive therapies for COVID-19 treatment

In a new study, researchers assessed the impact of baricitinib, netakimab, and tocilizumab against coronavirus disease 2019 (COVID-19).

31 Aug 2022

SARS-CoV-2 nucleocapsid antigen levels and patient outcomes

In a new study, researchers assessed the correlation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) antigen levels and hospitalized patient outcomes.

31 Aug 2022

Study explores differences in the efficiency of COVID-19 vaccine boosters

In a new study, researchers predicted the efficacy of coronavirus disease 2019 (COVID-19) vaccine boosters.

30 Aug 2022

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Researchers explored the molecular and cellular mechanisms of SARS-CoV-2 infection.

30 Aug 2022

Monkeypox virus detected on household items

The CDC study describes how the monkeypox virus spreads on household surfaces.

29 Aug 2022

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

In a new story, scientists explored human herpesvirus-6 (HHV-6) and Epstein–Barr virus (EBV) reactivation among acute coronavirus disease 2019 (COVID-19) patients.

29 Aug 2022

Study identifies two potential serological biomarkers of monkeypox infection

In a new study, researchers pursued two monkeypox virus (MPXV) immune targets, A35R and H3L, that could be deployed in a serological assay to identify recent MPXV cases.

29 Aug 2022

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Researchers investigated whether early treatment with oral antivirals prevented all-cause mortality in hospitalized patients infected with SARS-CoV-2 new variant of concern Omicron BA.2 subvariant.

29 Aug 2022

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Researchers assess the durability and effectiveness of immune responses against SARS-CoV-2 in terms of spike-binding antibody titers.

29 Aug 2022

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

A new study reported a single-cell adenovirus (SC-Ad) which replicates the antigen genes substantially without producing infectious progeny.

26 Aug 2022

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

Researchers evaluate infection rates and changes in the immunological history of COVID-19 patients over time.

25 Aug 2022

Susceptibility of deer mice and California mice to COVID-19

In a new study, researchers assessed the susceptibility of deer mice and California mice to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

25 Aug 2022

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

In a new study, the long-term humoral immunity to SARS-CoV-2 was investigated.

25 Aug 2022

Biological effects of nanoplastics in paints

A recent study analyzed paint composition and its biological properties, as paints release polymers and particles into the environment.

24 Aug 2022

Fast and sensitive paper-based nucleic acid assay for SARS-CoV-2

A paper-based diagnostic has been developed by Jinghong Li, Weimin Li, Ruijin Deng, and colleagues from Boston University for the identification of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high sensitivity.

23 Aug 2022

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

23 Aug 2022

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

Researchers demonstrated DNA origami as a potential platform to display the SARS-CoV-2 receptor-binding domain.

23 Aug 2022

What risk factors are associated with post-acute sequelae of SARS-CoV-2?

Researchers explored the risk factors correlated with post-acute sequelae of SARS-CoV-2.

23 Aug 2022

Assay News and Research

dsDNA Quantification for NGS Quality Control

Improving 1 µL UV-Vis Spectrophotometry Sample Results

Immunosuppressive therapies for COVID-19 treatment

SARS-CoV-2 nucleocapsid antigen levels and patient outcomes

Study explores differences in the efficiency of COVID-19 vaccine boosters

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Monkeypox virus detected on household items

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

Study identifies two potential serological biomarkers of monkeypox infection

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Study shows SARS-CoV-2 infection provides strong protection from reinfection

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

Susceptibility of deer mice and California mice to COVID-19

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

Biological effects of nanoplastics in paints

Fast and sensitive paper-based nucleic acid assay for SARS-CoV-2

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

What risk factors are associated with post-acute sequelae of SARS-CoV-2?

eBook: Using iPSCs models for human disease research and drug discovery eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News